Adeno-associated virus (AAV) is a uniquely versatile vector, valued for its ability to efficiently transduce a wide range of mammalian cells while being naturally non-pathogenic in humans and exhibiting low immunogenicity. Our custom AAV packaging services deliver high-purity single-and double-stranded vectors optimized for overexpression, shRNA-mediated knockdown, and CRISPR-SaCas9 gene editing. Leveraging proprietary technologies and reagents, we ensure superior viral titers, purity, potency, and consistency for reliable and reproducible experimental outcomes. Flexible packaging options accommodate both standard and ultra-low yield serotypes. Trusted by researchers worldwide, our AAV vectors accelerate gene function studies, streamline workflows, and support advanced functional genomics projects.
| Adeno-Associated Virus (AAV) Packaging | Titer | Turnaround Time | Deliverables |
| Ultra-purified ssAAV packaging (Regular-yield serotype) | 5E+12 VGS | 12~18 business days (turnaround time of plasmid construction not included) | Shipment Items (1) Custom AAV: Delivered per customer's requested quantity and aliquots; shipping list shows actual titer. (2) Control AAV: Delivered per customer's requested quantity and aliquots; shipping list shows actual titer. Electronic reports (1) COA(2) Instructions for use (3) Shipping list |
| 1E+13 VGS | |||
| 2E+13 VGS | |||
| 5E+13 VGS | |||
| 1E+14 VGS | |||
| Ultra-purified ssAAV packaging (Ultra-low-yield serotype) | 1E+12VGS | ||
| 2E+12 VGS | |||
| 5E+12 VGS | |||
| 1E+13 VGS | |||
| 2E+13 VGS | |||
| 5E+13 VGS | |||
| 1E+14 VGS | |||
| AAV RNAi (shRNA) / Knockout (CRISPR-SaCas9), Three targets (Regular yield) | 5E+11VGS | ||
| 1E+12VGS | |||
| 5E+12VGS | |||
| 1E+13VGS | |||
| 2E+13VGS | |||
| 5E+13VGS | |||
| AAV RNAi (shRNA) / Knockout (CRISPR-SaCas9), Three targets (Ultra-low yield) | 5E+11VGS | ||
| 1E+12VGS | |||
| 5E+12VGS | |||
| 1E+13VGS | |||
| 2E+13VGS | |||
| 5E+13VGS | |||
Ultra-purified scAAV packaging | 5E+11 VGS | ||
| 1E+12 VGS | |||
| 2E+12 VGS | |||
| 5E+12 VGS | |||
| 1E+13 VGS | |||
| 2E+13 VGS | |||
| 5E+13 VGS | |||
| 1E+14 VGS | |||
| 2E+14 VGS |
In Vitro Applications: Tsingke AAV viruses of different serotypes show good infection efficiency across various cell types.
The GFP fluorescence intensity in target cells depends on several factors, including the number of viral particles transducing the cells, the proliferative state of the cells, the cell type, and the observation time. Generally, the higher the number of viral particles transducing the target cells, and the faster the cell proliferation, the stronger the GFP fluorescence. For cells with faster proliferation, GFP expression typically peaks 48 to 72 hours after viral transduction. For slower proliferating cells, the GFP expression time will be extended.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
